Dan Wu
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
- Biochemistry 16
- Sulfur Compounds in Biology 12
-
- Traditional Chinese Medicine Analysis 6
- Journals
- PLoS ONE (8 papers)Oxidative Medicine and Cellular Longevity (5 papers)Oncotarget (5 papers)Scientific Reports (4 papers)Redox Biology (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Dan Wu
143 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Biochemistry 481
- Cancer Research 510
- Pharmacology 285
- Molecular Biology 2.2k
- Cardiology and Cardiovascular Medicine 586
Countries citing papers authored by Dan Wu
This map shows the geographic impact of Dan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Wu more than expected).
Fields of papers citing papers by Dan Wu
This network shows the impact of papers produced by Dan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Wu. The network helps show where Dan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2026 | 0 | |
| 3 | 2025 | 9 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 84 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 42 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 191 | |
| 14 | 2017 | 1 | |
| 15 | [Research Progress of Adipokines in Cardiac Fibrosis]. | 2015 | 1 |
| 16 | 2015 | 12 | |
| 17 | 2013 | 13 | |
| 18 | 2011 | 15 | |
| 19 | Research of Various Dosage Carnosine Affecting on Anti-Fatigue of motility for Rats | 2008 | 3 |
| 20 | 2002 | 9 |
About Dan Wu
Dan Wu is a scholar working on Biochemistry, Complementary and alternative medicine, Pharmacology, Molecular Biology and Physiology, having authored 153 papers that have together received 4.7k indexed citations. Recurring topics across this work include Sulfur Compounds in Biology (12 papers), Mitochondrial Function and Pathology (8 papers), Nitric Oxide and Endothelin Effects (7 papers), Medicinal Plants and Bioactive Compounds (7 papers), Traditional Chinese Medicine Analysis (6 papers), Adipose Tissue and Metabolism (6 papers), Pain Mechanisms and Treatments (6 papers) and Cardiac Fibrosis and Remodeling (6 papers). The work is most often cited by research in Biochemistry (481 citations), Cancer Research (510 citations), Pharmacology (285 citations), Molecular Biology (2.2k citations) and Cardiology and Cardiovascular Medicine (586 citations). Dan Wu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qingxun Hu, Yi Zhun Zhu, Francis Lin, Li‐Ling Wu, Fang Bian, Si Jin, Shasha Xing, Deqiu Zhu, Saravanan Nandagopal and Tao Zheng. Their work appears in journals such as PLoS ONE, Oxidative Medicine and Cellular Longevity, Oncotarget, Scientific Reports and Redox Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.